ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CLSD Clearside Biomedical Inc

1,40
0,00 (0,00%)
Pré-mercado
Última atualização: 08:13:38
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Clearside Biomedical Inc CLSD NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,00 0,00% 1,40 08:13:38
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,40
mais cotações »

Notícias Recentes

Data Hora Fonte Título
21/05/202408:05GLOBEClearside Biomedical Announces Publication of Consensus..
09/05/202417:05GLOBEClearside Biomedical Announces First Quarter 2024 Financial..
08/05/202417:15GLOBEClearside Biomedical to Participate in Fireside Chat at the..
30/04/202408:05GLOBEClearside Biomedical to Report First Quarter 2024 Financial..
16/04/202408:05GLOBEClearside Biomedical Appoints Seasoned Biotechnology..
02/04/202408:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
18/03/202408:05GLOBEClearside Biomedical Appoints Victor Chong, M.D., MBA as..
12/03/202417:05GLOBEClearside Biomedical Announces Fourth Quarter and Full Year..
29/02/202409:05GLOBEClearside Biomedical to Report Fourth Quarter and Full Year..
07/02/202410:00GLOBEClearside Biomedical Announces Pricing of $15 Million..
14/12/202309:05GLOBEClearside Biomedical Reports Significant Progress in ODYSSEY..
13/11/202318:05GLOBEClearside Biomedical Announces Third Quarter 2023 Financial..
08/11/202309:05GLOBEClearside Biomedical to Participate in Fireside Chat at the..
07/11/202318:20GLOBEClearside Biomedical’s Versatile Suprachoroidal Injection..
03/11/202313:00GLOBEBioCryst and Clearside Biomedical Enter Partnership to..
02/11/202308:05GLOBEClearside Biomedical Announces Presentations at the American..
01/11/202308:05GLOBEClearside Biomedical Completes Recruitment in ODYSSEY Phase..
31/10/202308:05GLOBEClearside Biomedical to Report Third Quarter 2023 Financial..
16/10/202308:05GLOBEClearside Biomedical Positive OASIS and Extension Study Data..
04/10/202310:00GLOBEClearside Biomedical Announces Advancement of XIPERE® in..
03/10/202317:35GLOBEClearside Biomedical to Participate in a Panel Discussion at..
19/09/202308:05GLOBEClearside Biomedical to Participate in Panel Discussion at..
14/08/202317:05GLOBEClearside Biomedical Announces Second Quarter 2023 Financial..
02/08/202317:30GLOBEClearside Biomedical to Participate in Upcoming Investor..
01/08/202308:05GLOBEClearside Biomedical to Report Second Quarter 2023 Financial..
31/07/202308:05GLOBEClearside Biomedical Highlights Excellent Safety Profile of..
20/07/202308:05GLOBEClearside Biomedical’s Suprachoroidal Injection Platform to..
17/07/202308:05GLOBEClearside Biomedical Announces Enrollment of Multiple..
11/07/202317:05GLOBEClearside Biomedical CEO George Lasezkay to Present at the..
10/07/202308:05GLOBEClearside Biomedical Asia-Pacific Partner Arctic Vision..